Staff editor
In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.
Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.
Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, discusses how celiac disease could become a model to study the link between gut microbiome and disease pathogenesis.
The therapy, combining human milk oligosaccharides (HMOs) and a specific gut bacteria strain, represents not only a scientific breakthrough but also holds substantial economic implications.
Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the future of microbiota modulation, with a focus on Microbial Therapeutics.
Industry
Sponsored by
Smiling ear to ear, supporting healthy teeth and mouth.
Industry
Sponsored by
This approval marks a significant leap forward in our understanding of holistic health and the intricate connection between our guts and our brains.
Francisco Guarner, from Centro Médico Teknon (Barcelona, Spain), talks about the recent update of the WGO’s Probiotics and prebiotics guidelines.
Bone resorption increases the risk of osteopenia and osteoporosis during and after menopause – learn about the importance of the gut microbiota to support healthy bones.
Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, talks about the mechanistic link between gut microbiome and disease pathogenesis and the impact on the future clinical practice.
